Major over reaction and a shot in the foot as far as confidence goes.
Find a new partner that's willing to either help with market penetration (and of course provide the funding necessary to close out the current financing) or get the current financing renegotiated.
This sector is ripe with shaky territory. Can they get things cleaned up by the end of March?
So really... Synergy is projecting TRULANCE total net sales for 2018 to be between $42.0 million to $47.0 million
That's not chicken feed. CRG should renegotiate to allow for better market penetration with a better view on the long term. I say it's worth the risk to see it through, at least for a bit. This news certainly may get to the right big pharma that may swallow them up.
All imho
Message in reply to:
Boo Dogg; What's your thought on this situation. I am long, should I pick up some or wait and see. Just wondering no big. GL
"Perfection is not attainable, but if we chase perfection we can catch excellence." Vince Lombardi Do your research! Play the TA. All posts are my opinion.